Physiologically based Kinetic Modeling-Facilitated Quantitative <i>In Vitro</i> to <i>In Vivo</i> Extrapolation to Predict the Effects of Aloe-Emodin in Rats and Humans
Qiuhui Ren, Jiaqi Chen, Sebastiaan Wesseling, Hans Bouwmeester, Ivonne M.C.M. Rietjens
Abstract
High Resolution Image Download MS PowerPoint Slide Aloe-emodin, a natural hydroxyanthraquinone, exerts both adverse and protective effects. This study aimed at investigating these potential effects of aloe-emodin in humans upon the use of food supplements and herbal medicines using a physiologically based kinetic (PBK) modeling-facilitated quantitative in vitro to in vivo extrapolation (QIVIVE) approach. For this, PBK models in rats and humans were established for aloe-emodin including its active metabolite rhein and used to convert in vitro data on hepatotoxicity, nephrotoxicity, reactive oxidative species (ROS) generation, and Nrf2 induction to corresponding in vivo dose–response curves, from which points of departure (PODs) were derived by BMD analysis. The derived PODs were subsequently compared to the estimated daily intakes (EDIs) resulting from the use of food supplements or herbal medicines. It is concluded that the dose levels of aloe-emodin from food supplements or herbal medicines are unlikely to induce toxicity, ROS generation, or Nrf2 activation in liver and kidney.